Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


Murine CD4+ T cell responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer.

Ma JZ, Lim SN, Qin JS, Yang J, Enomoto N, Ruedl C, Ronchese F.

PLoS One. 2012;7(5):e37481. doi: 10.1371/journal.pone.0037481. Epub 2012 May 23.


Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.

Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F.

Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):147-52. Epub 2005 Dec 22.


NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.

Stober D, Jomantaite I, Schirmbeck R, Reimann J.

J Immunol. 2003 Mar 1;170(5):2540-8.


Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.

Janicki CN, Jenkinson SR, Williams NA, Morgan DJ.

Cancer Res. 2008 Apr 15;68(8):2993-3000. doi: 10.1158/0008-5472.CAN-07-5008.


Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.

Wang Y, Da'Dara AA, Thomas PG, Harn DA.

Immunology. 2010 Mar;129(3):406-17. doi: 10.1111/j.1365-2567.2009.03193.x. Epub 2009 Nov 16.


Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo.

Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, Hermans IF, Ritchie DS, Yang J, Ronchese F.

J Immunol. 2008 Dec 15;181(12):8356-62.


Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.

Gaffal E, Schweichel D, Tormo D, Steitz J, Lenz J, Basner-Tschakarjan E, Limmer A, Tüting T.

Eur J Cell Biol. 2007 Dec;86(11-12):817-26. Epub 2006 Aug 22.


Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.

Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.

Immunology. 2006 Aug;118(4):483-96. Erratum in: Immunology. 2006 Sep;119(1):143.


Late dendritic cells are still able to evoke a potent alloreactive CTL response.

Repnik U, Bergant M, Wraber B, Jeras M.

Immunobiology. 2008;213(1):51-64. doi: 10.1016/j.imbio.2007.06.005. Epub 2007 Aug 6.


CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.

Serre K, Giraudo L, Siret C, Leserman L, Machy P.

Eur J Immunol. 2006 Jun;36(6):1386-97.


Autocrine, not paracrine, interferon-gamma gene delivery enhances ex vivo antigen-specific cytotoxic T lymphocyte stimulation and killing.

Zhang D, Liu Y, Shi M, You CX, Cao M, Luo RC, Hermonat PL.

J Biomed Biotechnol. 2010;2010:270985. doi: 10.1155/2010/270985. Epub 2010 May 13.


The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.

Riquelme E, Carreño LJ, González PA, Kalergis AM.

Eur J Immunol. 2009 Aug;39(8):2259-69. doi: 10.1002/eji.200939341.


Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells.

Faiola B, Doyle C, Gilboa E, Nair S.

Immunology. 2002 Jan;105(1):47-55. Erratum in: Immunology 2002 May;106(1):122-3.


Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.

McLellan AD, Kapp M, Eggert A, Linden C, Bommhardt U, Bröcker EB, Kämmerer U, Kämpgen E.

Blood. 2002 Mar 15;99(6):2084-93.


Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

Items per page

Supplemental Content

Write to the Help Desk